Back

Bullish Case: Optimism stems from Novartis' strategic acquisition, leveraging its resources for MorphoSys's oncology pipeline, particularly promising drugs pelabresib and tulmimetostat, aiming for H2 2024 regulatory nods.


Bearish Case: Setbacks could arise from regulatory hurdles or failure to achieve the tender offer threshold, compounded by MOR's recent underperformance relative to its 5-year high.


Potential Outcomes: 65% tender acceptance by shareholders (90%), successful regulatory nod in H2 2024 for pelabresib (80%), potential market overreaction to interim clinical data (15%).


Trading Oracle: Sign Up to access trading oracle trade ideas.


April 04, 2024


Morphosys Forecast

MOR        Morphosys
Price Forecast: BULLISH    Price Action: RANDOM (?)











Correlated Stock Forecasts

Assets that tend to move strongly with MOR



HRI Forecast + Options Trading Strategies   HRI  Herc (0.88)


RJF Forecast + Options Trading Strategies   RJF  Raymond James Financial (0.88)


LAZ Forecast + Options Trading Strategies   LAZ  Lazard (0.87)


PAVE Forecast + Options Trading Strategies   PAVE  Global X Funds - Global X U.S. Infrastructure Development (0.87)


XLI Forecast + Options Trading Strategies   XLI  Industrial Select Sector SPDR (0.87)



Uncorrelated Stock Forecasts

Assets with little price relationship to MOR



GOEV Forecast + Options Trading Strategies   GOEV  Canoo (0.0)


SSTK Forecast + Options Trading Strategies   SSTK  Shutterstock (-0.0)


ACCD Forecast + Options Trading Strategies   ACCD  Accolade (-0.01)


BYD Forecast + Options Trading Strategies   BYD  Boyd Gaming (-0.01)


ARLP Forecast + Options Trading Strategies   ARLP  Alliance Resource (0.01)



Anticorrelated Stock Forecasts

Assets that tend to move strongly against MOR



DXD Forecast + Options Trading Strategies   DXD  ProShares UltraShort Dow30 (-0.83)


SPXS Forecast + Options Trading Strategies   SPXS  Direxion Daily S&P 500 Bear 3X Shares (-0.84)


TZA Forecast + Options Trading Strategies   TZA  Direxion Daily Small Cap Bear 3X Shares (-0.85)


SRTY Forecast + Options Trading Strategies   SRTY  ProShares UltraPro Short Russell2000 (-0.85)


HUM Forecast + Options Trading Strategies   HUM  Humana (-0.86)





Become a more profitable investor with AI optimized trading strategies






×

Chat with MOR


 Ask any question about MOR!